§ Federal grant opportunity · PAR-28-014
Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)
National Institutes of Health is accepting applications for Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional). The deadline is October 11, 2029 and the published award range is Award amount not published.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- October 11, 2029
- Award range
- Award amount not published
- Eligibility
- nonprofits non higher education with 501c3, other, independent school districts, county governments, nonprofits non higher education without 501c3, state governments, for profit organizations other than small businesses, federally recognized native american tribal governments, private institutions of higher education, other native american tribal organizations, public and state institutions of higher education, public and indian housing authorities, small businesses, city or township governments, special district governments
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- PAR-28-014
Program overview
This Notice of Funding Opportunity (NOFO) invites applications that investigate the etiology of sporadic non-hereditary early-onset cancers (EOCs: ages 18 to 49 years) and the underlying biological mechanisms that play a role in these cancers to inform prevention and control strategies. The proposed research is expected to advance the understanding of the unexplained rise of cancers in young adults. More specifically, studies should focus on one or more of the following: i) identifying what environmental or lifestyle exposures are driving the increase in the incidence of non-hereditary EOCs, and how these factors vary by patient demographics; ii) examining the biological mechanisms and host responses that underlie the increase in EOCs; and iii) identifying how those at increased risk of developing EOCs can be identified more effectively. In an effort to streamline the application process and sustain momentum in this critical research area, this NOFO supports both exploratory/developmental and standard research projects through a grant award instrument.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before October 11, 2029, allowing time for registration and validation.
Related grant opportunities
- Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional)
- Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
- Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required)
- NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
- Research Initiatives at the Naval Postgraduate School
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.